TITLE

Safety and Efficacy of Carotid Angioplasty and Stenting in High-Risk Patients

AUTHOR(S)
Chaer, Rabih A.; Derubertis, Brian G.; Trocciola, Susan M.; Lin, Stephanie C.; Hynecek, Robert; Bush, Harry L.; Morrissey, Nicholas I.; McKinsey, James F.; Kent, K. Craig; Faries, Peter L.
PUB. DATE
August 2006
SOURCE
American Surgeon;Aug2006, Vol. 72 Issue 8, p694
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Performance of carotid endarterectomy (CEA) may be associated with an increased risk in patients with significant comorbid medical conditions, neck irradiation, or previous CEA. This study compared the results of CEA with carotid angioplasty and stenting (CAS) in high-risk patients treated for carotid stenosis. Five hundred forty-five patients who underwent CEA and 148 patients who underwent CAS were evaluated. For patients undergoing CEA, general anesthesia was used in 91 per cent, electroencephalographic monitoring was used in 63 per cent, and shunting was performed in 19.8 per cent. Cerebral protection devices were used in 145/148 of CAS cases, and self-expanding stents were used in all cases. Evaluated end points included major cardiovascular events, and a composite of death, stroke, or myocardial infarction for the duration of the follow-up. Mean follow-up was 18 months for CAS and 23 months for CEA. Significant differences were present in patient age (CAS, 75 ± 11.0 years vs CEA, 71 ± 9 years, P = 0.012), however, there were no significant differences (P = NS) in gender or smoking history. The mean modified Goldman Score was significantly higher for CAS (21.1 ± 14.8 [95% confidence interval = 18, 24]) than for CEA (6.3 ± 6.8 [95% confidence interval = 5.7, 6.9[; P = 0.0001) patients. The incidence of periprocedural complications did not vary significantly between patients treated with CAS (CVA, 1.4%; myocardial infarction [MI], 1.4%; death, 0.7%; CVA/MI/death, 3.4%) compared with CEA (CVA, 1.8%; MI, 1.1%; death, 0.4%; CVA/MI/death, 4.0%). CAS is equivalent to CEA in safety and efficacy, even when performed in patients who may be at increased surgical risk.
ACCESSION #
21879598

 

Related Articles

  • Primary angioplasty for ST-segment elevation myocardial infarction: Ready for prime time? Natarajan, Madhu K.; Yusuf, Salim // CMAJ: Canadian Medical Association Journal;7/8/2003, Vol. 169 Issue 1, p32 

    The treatment of ST-segment elevation myocardial infarction has undergone profound changes since the bedrest era of the 1960s. Most recently, the use of percutaneous coronary intervention (PCI) has been shown to be superior to thrombolysis. However, to be effective, PCI must be done as soon as...

  • Plaque sealing by coronary angioplasty. Meier, B. // Heart;Dec2004, Vol. 90 Issue 12, p1395 

    The article focuses on plaque sealing by coronary angioplasty. The plaque sealing principle has not been widely followed in spite of its theoretical appeal, mainly because of lack of documentation that balloon angioplasty indeed prevents subsequent myocardial infarction. The individual risk of a...

  • Early Carotid Artery Stenting and Angioplasty In Patients with Acute Ischemic Stroke. Clagett, G. Patrick // Perspectives in Vascular Surgery & Endovascular Therapy;Sep2005, Vol. 17 Issue 3, p273 

    The authors used a neurointerventional database in two university hospitals to study the safety of endovascular carotid angioplasty and stenting early (within 7 days) after an ischemic stroke. They reviewed clinical and radiologic data in 38 patients who had carotid angioplasty and stenting...

  • Coronary stent deployment to the iliac artery -- a complication with a successful treatment. Dziuba, Michał; Lenczewski, Piotr; Chiżyński, Krzysztof; Zielińska, Marzenna; Religa, Wojciech; Kaszyński, Marek; Stefańczyk, Ludomir; Kidawa, Michał // Advances in Interventional Cardiology;2012, Vol. 8 Issue 2, p146 

    We report a description of angioplasty (PCI) of the right coronary artery in a 68-year-old man with stable coronary artery disease and peripheral vascular atherosclerosis. The treatment was complicated by stent dislocation into the substantially narrowed iliac artery without accompanying signs...

  • What is Wrong With Cardiac Conditioning? We May be Shooting at Moving Targets. Iliodromitis, Efstathios K.; Cohen, Michael V.; Dagres, Nikolaos; Andreadou, Ioanna; Kremastinos, Dimitrios Th.; Downey, James M. // Journal of Cardiovascular Pharmacology & Therapeutics;Jul2015, Vol. 20 Issue 4, p357 

    Early recanalization of the occluded culprit coronary artery clearly reduces infarct size in both animal models and patients and improves clinical outcomes. Unfortunately, reperfusion can seldom be accomplished before some myocardium infarcts. As a result there has been an intensive search for...

  • Interventional treatment for stable angina pectoris is not superior to medical treatment. Margulescu, Andrei Dumitru // Maedica - a Journal of Clinical Medicine;2007, Vol. 2 Issue 2, p166 

    The article discusses the COURAGE study which examines the interventional treatment for stable angina pectoris wherein coronary balloon angioplasty has no effect when added to medical treatment. The study evaluated 2287 patients with stable angina pectoris who were randomized 1:1 coronary stent...

  • Long-Term Clinical Outcomes and Stent Thrombosis of Sirolimus-Eluting Versus Bare Metal Stents in Patients with End-Stage Renal Disease: Results of Korean Multicenter Angioplasty Team (KOMATE) Registry. BYEONG-KEUK KIM; SEUNGJIN OH; DONG WOON JEON; JOO YOUNG YANG; JUNG-SUN KIM; SUNGHA PARK; DONGHOON CHOI; YANGSOO JANG; BUM-KEE HONG; HYUK MOON KWON; SEUNG-WHAN LEE; CHOONG WON GOH; KIHWAN KWON; SUNG KEE RYU // Journal of Interventional Cardiology;Oct2009, Vol. 22 Issue 5, p411 

    Background: There are still controversies about long-term clinical outcomes of sirolimus-eluting stents (SES) versus bare metal stents (BMS) implantation in patients with end-stage renal diseases (ESRD). Objective: To compare long-term outcomes in patients with (ESRD) following SES versus BMS...

  • A 70-Year-Old Man With a Transient Ischemic Attack. Caplan, Louis R. // JAMA: Journal of the American Medical Association;7/2/2008, Vol. 300 Issue 1, p81 

    The article discuses a the medical case of a 70-year-old man with a history of severe coronary aortic, and peripheral artery disease, who presented at a hospital with slurred speech and left facial droop. The man had a transient ischemic stroke caused by severe preocclusive carotid artery...

  • Current Role of Laser Angioplasty of Restenotic Coronary Stents. Batyraliev, Talantbek A.; Pershukov, Igor V.; Niyazova-Karben, Zarema A.; Karaus, Alexandru; Calenici, Oleg; Guler, Niyazi; Eryonucu, Beyhan; Temamogullari, Alivahit; Ozgul, Sami; Akgul, Ferit; Sengul, Hakan; Dogru, Orhan; Demirbas, Onder; Timoshin, Ivan S.; Gaigukov, Alexei V.; Petrakova, Larisa N.; Peresypko, Marina K.; Sidorenko, Boris A. // Angiology;Jan/Feb2006, Vol. 57 Issue 1, p21 

    Treatment of in-stent restenosis (ISR) with conventional percutaneous transluminal coronary angioplasty (PTCA) causes significant recurrent neointimal tissue growth in 30-85%. Therefore, laser ablation of intrastent neointimal hyperplasia before balloon dilation can be an attractive alternative....

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics